Author

Chuwei Zhong

Children's Hospital of PhiladelphiaORCID 0000-0003-2406-2735Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Brian EnnisiD· 2 shared Daniel P. MilleriD· 2 shared Jo Lynne RokitaiD· 2 shared John M. MarisiD· 2 shared Komal S. RathiiD· 2 shared Miguel BrowniD· 2 shared Sharon J. DiskiniD· 2 shared Adam Cain ResnickiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Brian EnnisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsGigaSciencePeer-reviewedJan 1, 2025

The Open Pediatric Cancer Project

Zhuangzhuang Geng, Eric K. Wafula, Ryan J. Corbett…·Jo Lynne Rokita

The paper introduces OpenPedCan, a harmonized multi-omic dataset of pediatric cancer patients, providing integrated genomic, transcriptomic, and proteomic data for research and clinical applications.

16 citationstop 2%

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologyCancer CellPeer-reviewedOct 24, 2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Amber K. Weiner, Alexander B. Radaoui, Matthew Tsang…·Sharon J. Diskin

This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.

28 citationstop 3%

humanproteomics

𝕏 PostBluesky